Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
9580.00 | 31,122 Cr | 36.21 | 33.42 | 1.83 | 88.76 | 122.07 | 40.29 | ||
7798.00 | 25,376 Cr | 40.90 | 21.83 | 1.44 | 49.37 | 66.89 | 28.87 | ||
403.20 | 17,600 Cr | 22.70 | 6.02 | 1.49 | 26.51 | 27.65 | 20.21 | ||
120.60 | 16,183 Cr | 149.52 | 35.90 | 0.00 | 24.01 | 28.64 | 19.56 | ||
384.60 | 12,514 Cr | 62.58 | 8.86 | 0.00 | 14.16 | 17.48 | 9.57 | ||
575.00 | 7,456 Cr | 39.20 | 9.88 | 0.00 | 25.19 | 30.23 | 20.12 | ||
1103.05 | 1,995 Cr | 62.74 | 18.58 | 0.00 | 21.21 | 22.40 | 19.45 | ||
| Median: 7 Co. | — | 575.00 | 16,183 Cr | 40.90 | 18.58 | 0.00 | 25.19 | 28.64 | 20.12 |
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Emami Limited is a leading FMCG company in India, specializing in personal care and healthcare products, with prominent brands like Navratna, BoroPlus, and Zandu in its portfolio.
In Q3FY26, Emami achieved strong performance with consolidated net sales of ₹1,147 crore, growing by 11%, driven by a robust 9% volume growth in its domestic market and 9% growth in international business.
The company showcased successful innovation and portfolio expansion, launching products such as Kesh King Gold and BoroPlus variants. This strategy aligned with their focus on premiumization and capturing evolving consumer needs.
Emami's omnichannel approach has been effective, with organized channels contributing 32% of revenues. The company's digital strategy is advancing, with digital spending accounting for 50% of media expenses, enabling targeted consumer engagement.
The company declared a dividend of ₹6 per share as the second interim dividend for FY26, illustrating Emami's confidence in its financial performance and commitment to rewarding shareholders.
Personal Products
Personal Care
17,654 Cr
Low Risk
22.8
44.2
1.4
6.0
634.65
385.35
Sales CAGR
Profit CAGR
ROE
ROCE
Emami Ltd (EMAMILTD) is currently trading at 404.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Emami Limited is a leading FMCG company in India, specializing in personal care and healthcare products, with prominent brands like Navratna, BoroPlus, and Zandu in its portfolio. In Q3FY26, Emami achieved strong performance with consolidated net sales of ₹1,147 crore, growing by 11%, driven by a robust 9% volume growth in its domestic market and 9% growth in international business. The company showcased successful innovation and portfolio expansion, launching products such as Kesh King Gold and BoroPlus variants. This strategy aligned with their focus on premiumization and capturing evolving consumer needs. Emami's omnichannel approach has been effective, with organized channels contributing 32% of revenues. The company's digital strategy is advancing, with digital spending accounting for 50% of media expenses, enabling targeted consumer engagement. The company declared a dividend of ₹6 per share as the second interim dividend for FY26, illustrating Emami's confidence in its financial performance and commitment to rewarding shareholders.
Over the past 52 weeks, Emami Ltd has traded between a low of ₹385.35 and a high of ₹634.65. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Emami Ltd has a market capitalization of approximately 17,599.68. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Emami Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 22.70 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 17,599.68 Cr, Emami Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Emami Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Emami Ltd is 22.70. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The stock fell after Emami reported weaker-than-expected Q4FY26 numbers, including lower profit, revenue and EBITDA, and a drop in EBITDA margin to 20.2%.
Emami scheduled the investor conference call for May 21, 2026 at 4:00 PM IST, as per the announcement dated May 14, 2026.
Net sales were reported at a record ₹1,151.81 crore in the latest quarterly snapshot referenced.
Emami is acquiring a 60% stake in IncNut Digital on a fully diluted basis, as approved by its board on May 7, 2026.
Bearish
3
Neutral
3
Bullish
8
Bearish
35
Neutral
3
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Audited Results Publication
Emami Limited published newspaper clippings of its audited standalone and consolidated financial results for the quarter and year ended 31 March 2026; the Board approved the results on 21 May 2026.
Audited Results Publication
Emami Limited published audited standalone and consolidated financial results for the quarter and year ended 31 March 2026 (Board-approved 21 May 2026) via newspaper clippings in Business Standard and Aajkaal on 22 May 2026.
Quarterly Results
Emami reported audited Q4 FY26 & FY26 results: Q4 consolidated revenue ₹925cr (-4%), Q4 EBITDA ₹187cr, Q4 PAT ₹143cr; FY26 revenue ₹3,780cr, EBITDA ₹964cr, PAT ₹775cr; gross margin expansion; interim dividend ₹10/sh.
Earnings Presentation
Emami released audited Q4/FY26 results: Q4 consolidated revenue down 4% to ₹925cr, EBITDA ₹187cr, PAT ₹143cr; FY26 revenue ₹3,780cr, EBITDA ₹964cr, PAT ₹775cr; declared interim dividend ₹10/sh and acquired Axiom (subsidiary) and majority stake in IncNut.
Quarterly Results & Acquisitions
Emami reported audited Q4FY26 consolidated revenue down 4% to ₹925 crore (Q4 EBITDA ₹187 crore, PAT ₹143 crore); FY26 revenue ₹3,780 crore, EBITDA ₹964 crore, PAT ₹775 crore, margin expansion, strategic stakes in Axiom and IncNut, and ₹10 interim dividend.
Earnings Release
Emami reported Q4FY26 consolidated revenue down 4% to ₹925 crore (Q4 EBITDA ₹187cr, PAT ₹143cr); FY26 revenue ₹3,780cr, EBITDA ₹964cr, PAT ₹775cr; margin expansion; stake in Axiom Ayurveda made subsidiary and majority stake in IncNut acquired; interim dividends ₹436.5cr.
